European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer

Lawler, 2021, The European Code of Cancer Practice, J Cancer Policy, 28, 10.1016/j.jcpo.2021.100282 Albreht T, Kiasuma R, Van den Bulcke M. Cancon Guide – Improving cancer control coordination; 2017. https://cancercontrol.eu/archived/cancercontrol.eu/guide-landing-page/index.html. Prades, 2015, Is it worth re-organising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes, Health Policy, 119, 464, 10.1016/j.healthpol.2014.09.006 Borràs, 2014, Policy statement on multidisciplinary cancer care, Eur J Cancer, 50, 475, 10.1016/j.ejca.2013.11.012 Cardoso, 2017, European Breast Cancer Conference manifesto on breast centres/units, Eur J Cancer, 72, 244, 10.1016/j.ejca.2016.10.023 Prades, 2020, Bratislava Statement: consensus recommendations for improving pancreatic cancer care, ESMO Open, 5, 10.1136/esmoopen-2020-001051 Borràs JM, Prades J, Coll C. Report with recommendations for improving access to expert clinicians in reference hospitals concerning patients’ diagnosis and treatment of pancreatic cancer, and its potential impact on outcomes. iPAAC, 2020. https://bit.ly/311dPEQ. European Cancer Information System. https://ecis.jrc.ec.europa.eu/index.php. Ferlay, 2018, Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018, Eur J Cancer, 103, 356, 10.1016/j.ejca.2018.07.005 Lepage, 2015, Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: results of EUROCARE-5, Eur J Cancer, 51, 2169, 10.1016/j.ejca.2015.07.034 United European Gastroenterology. Pancreatic cancer across Europe. Taking a united stand. https://bit.ly/39JU9KO. Carrato, 2015, A systematic review of the burden of pancreatic cancer in Europe: real-world impact on survival, quality of life and costs, J Gastrointest Cancer, 46, 201, 10.1007/s12029-015-9724-1 Ferlay, 2016, More deaths from pancreatic cancer than breast cancer in the EU by 2017, Acta Oncol, 55, 1158, 10.1080/0284186X.2016.1197419 Rahib, 2014, Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States, Cancer Res, 74, 2913, 10.1158/0008-5472.CAN-14-0155 McGuigan, 2018, Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes, World J Gastroenterol, 24, 4846, 10.3748/wjg.v24.i43.4846 Permuth-Wey, 2009, Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis, Fam Cancer, 8, 109, 10.1007/s10689-008-9214-8 Ducreux, 2015, Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 26, v56, 10.1093/annonc/mdv295 Grossberg, 2020, Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma, CA Cancer J Clin, 70, 375, 10.3322/caac.21626 Taieb, 2020, How I treat pancreatic cancer, ESMO Open, 4 Hidalgo, 2010, Pancreatic cancer, N Engl J Med, 362, 1605, 10.1056/NEJMra0901557 Willett, 2005, Locally advanced pancreatic cancer, J Clin Oncol, 23, 4538, 10.1200/JCO.2005.23.911 Neoptolemos, 2017, Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial, Lancet, 389, 1011, 10.1016/S0140-6736(16)32409-6 Conroy, 2018, FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer, N Engl J Med, 379, 2395, 10.1056/NEJMoa1809775 Murphy, 2018, Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial, JAMA Oncol, 4, 963, 10.1001/jamaoncol.2018.0329 Janssen, 2019, Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis, J Natl Cancer Inst, 111, 782, 10.1093/jnci/djz073 Okusaka, 2020, Clinical practice guidelines for pancreatic cancer 2019 from the Japan Pancreas Society: a synopsis, Pancreas, 49, 326, 10.1097/MPA.0000000000001513 Conroy, 2011, FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer, N Engl J Med, 364, 1817, 10.1056/NEJMoa1011923 Von Hoff, 2013, Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine, N Engl J Med, 369, 1691, 10.1056/NEJMoa1304369 Suker, 2016, FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis, Lancet Oncol, 17, 801, 10.1016/S1470-2045(16)00172-8 Naudin, 2019, Healthy lifestyle and the risk of pancreatic cancer in the EPIC study, Eur J Epidemiol, 35, 975, 10.1007/s10654-019-00559-6 Schmidt-Hansen, 2016, Symptoms of pancreatic cancer in primary care: a systematic review, Pancreas, 45, 814, 10.1097/MPA.0000000000000527 National Cancer Registration and Analysis Service. Routes to diagnosis 2006-2015. http://www.ncin.org.uk/publications/routes_to_diagnosis. European Study Group on Cystic Tumours of the Pancreas, 2018, European evidence-based guidelines on pancreatic cystic neoplasms, Gut, 67, 789, 10.1136/gutjnl-2018-316027 Zhang, 2018, Challenges in diagnosis of pancreatic cancer, World J Gastroenterol, 24, 2047, 10.3748/wjg.v24.i19.2047 Eloubeidi, 2003, Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma, Cancer, 99, 285, 10.1002/cncr.11643 Soloff, 2018, Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease, Abdom Radiol (NY), 43, 301, 10.1007/s00261-017-1410-2 Isaji, 2018, International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017, Pancreatology, 18, 2, 10.1016/j.pan.2017.11.011 Kirkegård, 2019, Multicentre study of multidisciplinary team assessment of pancreatic cancer resectability and treatment allocation, Br J Surg, 106, 756, 10.1002/bjs.11093 Polonski, 2019, Centralization of pancreatic surgery in Europe, J Gastrointest Surg, 23, 2081, 10.1007/s11605-019-04215-y Jaap, 2018, Analyzing the impact of compliance with national guidelines for pancreatic cancer care using the National Cancer Database, J Gastrointest Surg, 22, 1358, 10.1007/s11605-018-3742-9 Sreedharan, 2019, Bridging clinic: the initial medical management of patients with newly diagnosed pancreatic cancer, Frontline Gastroenterol, 10, 261, 10.1136/flgastro-2018-101002 Weniger, 2020, Improvement of survival after surgical resection of pancreatic cancer independent of adjuvant chemotherapy in the past two decades – a meta-regression, Eur J Surg Oncol, 46, 1516, 10.1016/j.ejso.2020.02.016 Klaiber, 2019, Adjuvant treatment for pancreatic cancer, Transl Gastroenterol Hepatol, 4, 27, 10.21037/tgh.2019.04.04 Huang, 2019, Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations, Gut, 68, 130, 10.1136/gutjnl-2017-314828 Mavros, 2019, Low rates of specialized cancer consultation and cancer-directed therapy for noncurable pancreatic adenocarcinoma: a population-based analysis, CMAJ, 191, E574, 10.1503/cmaj.190211 Abdel-Rahman, 2018, A real-world, population-based study of patterns of referral, treatment, and outcomes for advanced pancreatic cancer, Cancer Med, 7, 6385, 10.1002/cam4.1841 Zijlstra, 2018, Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands, Acta Oncol, 57, 1185, 10.1080/0284186X.2018.1470330 Scott E, Jewell A. Supportive care needs of people with pancreatic cancer: a literature review. Cancer Nurs Pract. 2019;10 January. http://doi.org/10.7748/cnp.2019.e1566. Mueller, 2014, Cachexia and pancreatic cancer: are there treatment options?, World J Gastroenterol, 20, 9361 Koulouris, 2017, Pain in patients with pancreatic cancer: prevalence, mechanisms, management and future developments, Dig Dis Sci, 62, 861, 10.1007/s10620-017-4488-z Bhattacharya, 2018, Palliative care in lung cancer: when to start, Curr Oncol Rep, 20, 90, 10.1007/s11912-018-0731-9 Temel, 2017, Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial, J Clin Oncol, 35, 834, 10.1200/JCO.2016.70.5046 Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY, et al. Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer. JAMA 319(23):2401–9. http://doi.org/10.1001/jama.2018.6228. Lorenzo, 2019, Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer, World J Gastroenterol, 25, 5082, 10.3748/wjg.v25.i34.5082 Rutgers, 2019, European Breast Cancer Council manifesto 2018: genetic risk prediction testing in breast cancer, Eur J Cancer, 106, 45, 10.1016/j.ejca.2018.09.019 Cherny, 2016, ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe, Ann Oncol, 27, 1423, 10.1093/annonc/mdw213 Lievens, 2020, Provision and use of radiotherapy in Europe, Mol Oncol, 14, 1461, 10.1002/1878-0261.12690 Grau, 2014, Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey, Radiother Oncol, 112, 155, 10.1016/j.radonc.2014.08.029 Pancreatic Cancer Europe. Pancreatic cancer inequality report. https://bit.ly/2JTbOFi. Xie, 2020, Role of surgery and perioperative therapy in older patients with resectable pancreatic ductal adenocarcinoma, Oncologist, 25, e1681, 10.1634/theoncologist.2020-0086 van Roest, 2016, The impact of socioeconomic status, surgical resection and type of hospital on survival in patients with pancreatic cancer. A population-based study in the Netherlands, PLoS ONE, 11, 10.1371/journal.pone.0166449 Pancreatic Cancer Europe. Pancreatic cancer research in Europe. Multistakeholder brainstorming meeting. 12 April 2017. https://bit.ly/37L81BV. Zhu, 2018, Pancreatic cancer: challenges and opportunities, BMC Med, 16, 214, 10.1186/s12916-018-1215-3 Singhi, 2019, Early detection of pancreatic cancer: opportunities and challenges, Gastroenterology, 156, 2024, 10.1053/j.gastro.2019.01.259 Orth, 2019, Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches, Radiat Oncol, 14, 141, 10.1186/s13014-019-1345-6 United European Gastroenterology. Pancreatic cancer death rates rising across Europe, report reveals. Press release, 15 November 2018. https://bit.ly/33RWUGa. Forsea, 2016, Cancer registries in Europe – going forward is the only option, Ecancermedicalscience, 10, 641, 10.3332/ecancer.2016.641 Siesling, 2015, Uses of cancer registries for public health and clinical research in Europe: results of the European Network of Cancer Registries survey among 161 population-based cancer registries during 2010–2012, Eur J Cancer, 51, 1039, 10.1016/j.ejca.2014.07.016 National Institute for Health and Care Excellence. Pancreatic cancer overview. https://pathways.nice.org.uk/pathways/pancreatic-cancer. Cancer Council Victoria. Optimal care pathway for people with pancreatic cancer. https://bit.ly/33R0Tmt. Marchegiani, 2018, Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma?, HPB (Oxford), 20, 411, 10.1016/j.hpb.2017.10.017 Seo, 2018, The survival impact of surgical waiting time in patients with resectable pancreatic head cancer, Ann Hepatobiliary Pancreat Surg, 22, 405, 10.14701/ahbps.2018.22.4.405 National Institute for Health and Care Excellence. Pancreatic cancer in adults: diagnosis and management. NICE guideline [NG85]. https://www.nice.org.uk/guidance/ng85. van der Geest, 2016, Volume-outcome relationships in pancreatoduodenectomy for cancer, HPB (Oxford), 18, 317, 10.1016/j.hpb.2016.01.515 Mamidanna, 2016, Surgeon volume and cancer esophagectomy, gastrectomy, and pancreatectomy: a population-based study in England, Ann Surg, 263, 727, 10.1097/SLA.0000000000001490 Ahola, 2020, Centralization of pancreatic surgery improves results: review, Scand J Surg, 109, 4, 10.1177/1457496919900411 Faraj, 2019, Perioperative management of pancreaticoduodenectomy: avoiding admission to the intensive care unit, Gastrointest Tumors, 6, 108, 10.1159/000502887 van Rijssen, 2018, Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide audit, HPB (Oxford), 20, 759, 10.1016/j.hpb.2018.02.640 Enestvedt, 2012, Complications nearly double the cost of care after pancreaticoduodenectomy, Am J Surg, 204, 332, 10.1016/j.amjsurg.2011.10.019 Williamsson, 2017, Postoperative pancreatic fistula-impact on outcome, hospital cost and effects of centralization, HPB (Oxford), 19, 436, 10.1016/j.hpb.2017.01.004 Pawlik, 2008, Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer, Ann Surg Oncol, 15, 2081, 10.1245/s10434-008-9929-7 Basta, 2016, Is there a benefit of multidisciplinary cancer team meetings for patients with gastrointestinal malignancies?, Ann Surg Oncol, 23, 2430, 10.1245/s10434-016-5178-3 Basta, 2017, The value of multidisciplinary team meetings for patients with gastrointestinal malignancies: a systematic review, Ann Surg Oncol, 24, 2669, 10.1245/s10434-017-5833-3 Hansen, 2020, The results of pancreatic operations after the implementation of multidisciplinary team conference (MDT): a quality improvement study, Int J Surg, 77, 105, 10.1016/j.ijsu.2020.03.045 SONCOS. Standardisation of Multidisciplinary Care in the Netherlands. SONCOS Standardisation Report 5. https://bit.ly/33RXdki. Belgian Health Care Knowledge Centre. Cancers of the pancreas. Preferred model of care and criteria for reference centres. KCE report 219 addendum. https://bit.ly/2W6Rbry. De Schutter, 2018, Relation between center volumes for pancreatic and esophageal cancer surgeries and outcome in Belgium: a plea for centralization, Ann Oncol, 29, viii562, 10.1093/annonc/mdy297.001 Balzano, 2020, Modelling centralization of pancreatic surgery in a nationwide analysis, Br J Surg, 107, 1510, 10.1002/bjs.11716 Polkowski, 2017, Technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline – March 2017, Endoscopy, 49, 989, 10.1055/s-0043-119219 Banafea, 2016, Endoscopic ultrasonography with fine-needle aspiration for histological diagnosis of solid pancreatic masses: a meta-analysis of diagnostic accuracy studies, BMC Gastroenterol, 16, 108, 10.1186/s12876-016-0519-z Hébert-Magee, 2013, The presence of a cytopathologist increases the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration cytology for pancreatic adenocarcinoma: a meta-analysis, Cytopathology, 24, 159, 10.1111/cyt.12071 Pitman, 2014, Guidelines for pancreaticobiliary cytology from the Papanicolaou Society of Cytopathology: a review, Cancer Cytopathol, 122, 399, 10.1002/cncy.21427 Kakar, S., Shi, C., Adsay, N.V., Fitzgibbons, P., Frankel, W.L., Klimstra, D.S., et al. Protocol for the examination of specimens from patients with carcinoma of the pancreas. College of American Pathologists. https://capatholo.gy/3mVMjBm. Zins, 2018, Pancreatic adenocarcinoma staging in the era of preoperative chemotherapy and radiation therapy, Radiology, 287, 374, 10.1148/radiol.2018171670 Brennan, 2007, Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT, Radiographics, 27, 1653, 10.1148/rg.276075034 Bowman, 2019, MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging, Abdom Radiol (NY), 44, 936, 10.1007/s00261-018-1686-x Kim, 2019, Incremental role of pancreatic magnetic resonance imaging after staging computed tomography to evaluate patients with pancreatic ductal adenocarcinoma, Cancer Res Treat, 51, 24, 10.4143/crt.2017.404 Marion-Audibert, 2018, Routine MRI with DWI sequences to detect liver metastases in patients with potentially resectable pancreatic ductal carcinoma and normal liver CT: a prospective multicenter study, AJR Am J Roentgenol, 211, W217, 10.2214/AJR.18.19640 Ito, 2017, The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer, Pancreatology, 17, 451, 10.1016/j.pan.2017.03.001 Marin, 2010, Detection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase: effect of a low-tube-voltage, high-tube-current CT technique – preliminary results, Radiology, 256, 450, 10.1148/radiol.10091819 Jha, 2018, The role of MR imaging in pancreatic cancer, Magn Reson Imaging Clin N Am, 26, 363, 10.1016/j.mric.2018.03.004 Khalsa, 2015, Evolution in the treatment of delayed postpancreatectomy hemorrhage: surgery to interventional radiology, Pancreas, 44, 953, 10.1097/MPA.0000000000000347 Boellaard, 2015, FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0, Eur J Nucl Med Mol Imaging, 42, 328, 10.1007/s00259-014-2961-x National Comprehensive Cancer Network (NCCN). NCCN Guidelines for Pancreatic Adenocarcinoma. https://www.nccn.org/professionals/physician_gls/default.aspx. Qayyum, 2017, ACR Appropriateness Criteria staging of pancreatic ductal adenocarcinoma, J Am Coll Radiol, 14, S560, 10.1016/j.jacr.2017.08.050 Daamen, 2018, The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis, Eur J Radiol, 106, 128, 10.1016/j.ejrad.2018.07.010 Clancy, 2015, Surgery for pancreatic cancer, Hematol Oncol Clin North Am, 29, 701, 10.1016/j.hoc.2015.04.001 Maggino, 2017, Recent advances in pancreatic cancer surgery, Curr Treat Options Gastroenterol, 15, 520, 10.1007/s11938-017-0150-2 Oettle, 2013, Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial, JAMA, 310, 1473, 10.1001/jama.2013.279201 Burris, 1997, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial, J Clin Oncol, 15, 2403, 10.1200/JCO.1997.15.6.2403 Huguet, 2007, Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies, J Clin Oncol, 25, 326, 10.1200/JCO.2006.07.5663 Versteijne, 2020, Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial, J Clin Oncol, 38, 1763, 10.1200/JCO.19.02274 Rwigema, 2011, Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas, Am J Clin Oncol, 34, 63, 10.1097/COC.0b013e3181d270b4 Palta, 2019, Radiation therapy for pancreatic cancer: executive summary of an ASTRO clinical practice guideline, Pract Radiat Oncol, 9, 322, 10.1016/j.prro.2019.06.016 Brunner, 2020, ESTRO ACROP guidelines for target volume definition in pancreatic cancer, Radiother Oncol, 154, 60, 10.1016/j.radonc.2020.07.052 Green LM. Meeting the complex needs of patients with pancreatic cancer. Oncol Nurs News 2015;9(3). https://bit.ly/3aPprgL. Mohammed, 2020, ‘I’m going to push this door open. You can close it’: a qualitative study of the brokering work of oncology clinic nurses in introducing early palliative care, Palliat Med, 34, 209, 10.1177/0269216319883980 European Oncology Nursing Society (EONS). EONS Cancer Nursing Education Framework. https://bit.ly/33QHhPF. Lassen, 2012, Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS) Society recommendations, Clin Nutr, 31, 817, 10.1016/j.clnu.2012.08.011 Bouvier, 2017, Focus on an unusual rise in pancreatic cancer incidence in France, Int J Epidemiol, 46, 1764, 10.1093/ije/dyx088 Turrini, 2013, Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association, Eur J Surg Oncol, 39, 171, 10.1016/j.ejso.2012.08.017 Macchini, 2018, Chemotherapy in elderly patients with pancreatic cancer: efficacy, feasibility and future perspectives, Cancer Treat Rev, 72, 1, 10.1016/j.ctrv.2018.10.013 Ciabatti, 2019, Radiotherapy of pancreatic cancer in older patients: a systematic review, J Geriatr Oncol, 10, 534, 10.1016/j.jgo.2018.09.007 Petit-Monéger, 2016, Detection of frailty in elderly cancer patients: improvement of the G8 screening test, J Geriatr Oncol, 7, 99, 10.1016/j.jgo.2016.01.004 Martinez-Tapia, 2017, Prognostic value of the G8 and modified-G8 screening tools for multidimensional health problems in older patients with cancer, Eur J Cancer, 83, 211, 10.1016/j.ejca.2017.06.027 Hamaker, 2018, The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients – a systematic review, J Geriatr Oncol, 9, 430, 10.1016/j.jgo.2018.03.014 Wildiers, 2014, International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer, J Clin Oncol, 32, 2595, 10.1200/JCO.2013.54.8347 Borson, 2003, The Mini-Cog as a screen for dementia: validation in a population-based sample, J Am Geriatr Soc, 51, 1451, 10.1046/j.1532-5415.2003.51465.x Kim, 2016, DELirium prediction based on hospital information (Delphi) in general surgery patients, Medicine (Baltimore), 95, 10.1097/MD.0000000000003072 European Society of Oncology Pharmacy. Quality Standard for the Oncology Pharmacy Service (QuapoS 6). https://esop.li/quapos. Brintzenhofe-Szoc, 2009, Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type, Psychosomatics, 50, 383, 10.1176/appi.psy.50.4.383 Holland, 1986, Comparative psychological disturbance in patients with pancreatic and gastric cancer, Am J Psychiatry, 143, 982, 10.1176/ajp.143.8.982 Warner-Cohen, 2020, Increasing access to multidisciplinary care in pancreatic cancer, Psychooncology, 29, 2105, 10.1002/pon.5493 Haun, 2017, Early palliative care for adults with advanced cancer, Cochrane Database Syst Rev, 12, CD011129 Kavalieratos, 2016, Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis, JAMA, 316, 2104, 10.1001/jama.2016.16840 Aapro, 2012, Supportive care and palliative care: a time for unity in diversity, Ann Oncol, 23, 1932, 10.1093/annonc/mds239 Jordan, 2018, European Society for Medical Oncology (ESMO) position paper on supportive and palliative care, Ann Oncol, 29, 36, 10.1093/annonc/mdx757 Védie, 2019, Pancreatic cancer: best supportive care, Presse Med, 48, e175e185 Jang, 2015, Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer, J Natl Cancer Inst, 107, 10.1093/jnci/dju424 Maltoni, 2016, Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial, Eur J Cancer, 65, 61, 10.1016/j.ejca.2016.06.007 Maltoni, 2016, Systematic versus on-demand early palliative care: a randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life, Eur J Cancer, 69, 110, 10.1016/j.ejca.2016.10.004 Udelsman, 2019, Deficits in the palliative care process measures in patients with advanced pancreatic cancer undergoing operative and invasive nonoperative palliative procedures, Ann Surg Oncol, 26, 4204, 10.1245/s10434-019-07757-2 Ferrell, 2017, Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update, J Clin Oncol, 35, 96, 10.1200/JCO.2016.70.1474 Quill, 2013, Generalist plus specialist palliative care – creating a more sustainable model, N Engl J Med, 368, 1173, 10.1056/NEJMp1215620 Gilliland, 2017, Nutritional and metabolic derangements in pancreatic cancer and pancreatic resection, Nutrients, 9, 243, 10.3390/nu9030243 Weimann, 2017, ESPEN guideline: clinical nutrition in surgery, Clin Nutr, 36, 623, 10.1016/j.clnu.2017.02.013 Arends, 2017, ESPEN guidelines on nutrition in cancer patients, Clin Nutr, 36, 11, 10.1016/j.clnu.2016.07.015 Afaneh, 2015, Pancreatic cancer surgery and nutrition management: a review of the current literature, Hepatobiliary Surg Nutr, 4, 59 Hart, 2016, Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer, Lancet Gastroenterol Hepatol, 1, 226, 10.1016/S2468-1253(16)30106-6 Andersen, 2017, Diabetes, pancreatogenic diabetes, and pancreatic cancer, Diabetes, 66, 1103, 10.2337/db16-1477 Daly, 2020, NCCN Guidelines Insights: Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020., J Natl Compr Canc Netw, 18, 380, 10.6004/jnccn.2020.0017 Pavel, 2020, Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 31, 844, 10.1016/j.annonc.2020.03.304 Buicko, 2019, Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors, Ann Pancreat Cancer, 2, 12, 10.21037/apc.2019.06.02 Jin, 2018, Supportive therapy in gastroenteropancreatic neuroendocrine tumors: often forgotten but important, Rev Endocr Metab Disord, 19, 145, 10.1007/s11154-018-9443-6 Cocchiara RA, Follmann M, La Torre G, Wesselmann S, Lia L, Dorelli B, et al. Quality indicators for colorectal and pancreatic cancer to monitor and improve oncological care within comprehensive cancer care networks (CCCN). iPAAC, 2020. https://bit.ly/3w5hKyj. Wind, 2016, Quality assessments for cancer centers in the European Union, BMC Health Serv Res, 16, 474, 10.1186/s12913-016-1738-2 van Rijssen, 2017, Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit, HPB (Oxford), 19, 919, 10.1016/j.hpb.2017.06.010 Mackay, 2020, Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up, Pancreatology, 20, 1723, 10.1016/j.pan.2020.10.032 National Institute for Health and Care Excellence. Pancreatic cancer. Quality standard [QS177]. https://www.nice.org.uk/guidance/qs177. German Cancer Society (DKG). Annual report 2019 of the certified pancreatic cancer centres. Audit year 2018/Indicator year 2017. https://ecc-cert.org/annual-reports. Tingstedt, 2019, First results from the Swedish National Pancreatic and Periampullary Cancer Registry, HPB (Oxford), 21, 34, 10.1016/j.hpb.2018.06.1811 Fristrup, 2016, Danish Pancreatic Cancer Database, Clin Epidemiol, 8, 645, 10.2147/CLEP.S99471 Maharaj, 2019, Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus, HPB (Oxford), 21, 444, 10.1016/j.hpb.2018.08.016 Sánchez-Velázquez, 2019, Benchmarks in pancreatic surgery: a novel tool for unbiased outcome comparisons, Ann Surg, 270, 211, 10.1097/SLA.0000000000003223 Wellner UF, Klinger C, Lehmann K, Buhr H, Neugebauer E, Keck T. The pancreatic surgery registry (StuDoQ|Pancreas) of the German Society for General and Visceral Surgery (DGAV) – presentation and systematic quality evaluation. Trials 2017;18(1):163. http://doi.org/10.1186/s13063-017-1911-x. Bolm, 2019, The impact of preoperative biliary stenting in pancreatic cancer: a case-matched study from the German nationwide pancreatic surgery registry (DGAV StuDoQ|Pancreas), Pancreatology, 19, 985, 10.1016/j.pan.2019.09.007 Probst, 2019, Evidence map of pancreatic surgery: protocol for a living systematic review and meta-analysis, BMJ Open, 9, 10.1136/bmjopen-2019-032353 van der Heijde N, Vissers FL, Boggi U, Dokmak S, Edwin B, Hackert T, et al. Designing the European registry on minimally invasive pancreatic surgery: a pan-European survey. HPB (Oxford). 2020;23(4):566–74. http://doi.org/10.1016/j.hpb.2020.08.015. Stevenson-Hornby, 2018, A rapid-access diagnostic pathway in suspected pancreatic cancer, Nurs Times, 114, 34 Benstead, 2017, Multidisciplinary training of cancer specialists in Europe, Eur J Cancer, 83, 1, 10.1016/j.ejca.2017.05.043 White, 2019, Advanced pancreatic cancer clinical trials: the continued underrepresentation of older patients, J Geriatr Oncol, 10, 540, 10.1016/j.jgo.2018.11.001 Paillaud, 2018, Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: a French initiative with international survey, Eur J Cancer, 103, 61, 10.1016/j.ejca.2018.07.137